Dermapharm Holding SE
Dermapharm Holding SE, headquartered in Germany, is a prominent player in the pharmaceutical industry, specialising in the development and production of high-quality generic and specialty pharmaceuticals. Founded in 1991, the company has established a strong presence across Europe, with significant operations in various key markets. The firm is renowned for its innovative approach to drug formulation, focusing on areas such as pain management, oncology, and central nervous system disorders. Dermapharm's commitment to quality and efficiency has positioned it as a trusted partner for healthcare providers and patients alike. With a robust portfolio of products, Dermapharm continues to achieve notable milestones, reinforcing its status as a leader in the pharmaceutical sector.
DitchCarbon Score
How does Dermapharm Holding SE's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Dermapharm Holding SE's score of 22 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Dermapharm Holding SE's reported carbon emissions
Dermapharm Holding SE, headquartered in Germany, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is identified as a current subsidiary and inherits its climate commitments and performance metrics from its parent organization, Dermapharm Holding SE. Despite the lack of specific emissions data, Dermapharm is engaged in various climate initiatives, although no specific reduction targets or pledges have been documented. The absence of detailed information on their climate commitments suggests that Dermapharm may still be in the process of establishing or formalising its sustainability strategies. As a subsidiary, Dermapharm's climate actions may align with broader corporate family initiatives, but specific details regarding these initiatives or any cascading targets from parent organisations are not available. Overall, while Dermapharm Holding SE is positioned within the pharmaceutical sector, its current climate commitments and emissions data remain unspecified.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Dermapharm Holding SE is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
